Daewon Pharmaceutical Co (XKRX:003220) Other Income (Minority Interest) : ₩5,429 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Daewon Pharmaceutical Co Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Daewon Pharmaceutical Co's Other Income (Minority Interest) for the three months ended in Mar. 2025 was ₩524 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩5,429 Mil.

Daewon Pharmaceutical Co Other Income (Minority Interest) Historical Data

The historical data trend for Daewon Pharmaceutical Co's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewon Pharmaceutical Co Other Income (Minority Interest) Chart

Daewon Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Minority Interest)

Get a 7-Day Free Trial

441.90

378.15

1,287.18

453.67

5,164.81

Daewon Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Minority Interest)	Get a 7-Day Free Trial															259.25	1,504.20	1,146.61	2,254.75	523.67

Daewon Pharmaceutical Co Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,429 Mil.

Daewon Pharmaceutical Co (XKRX:003220) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Daewon Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Other Income (Minority Interest)

Traded in Other Exchanges

N/A

Address

229-3 Yongdap-dong, Seongdong-gu, Seoul, KOR, 133-850

Website

https://www.daewonpharm.com

Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.

Daewon Pharmaceutical Co Headlines

No Headlines